JN: "Journal of the National Cancer Institute [J Natl Cancer Inst] NLMUID: 7503089" - OpacWWW

Skocz do pozycji: 1 1.

Tytuł :: Trends of Cancer-Related Suicide in the United States: 1999-2018.
Autorzy :: Han X; Surveillance and Health Services Research, Intramural Research Department, American Cancer Society, Atlanta, GA, USA.
Hu X; Department of Health Policy and Management, Rollins School of Public Health, Emory University, Atlanta, GA, USA.
Zhao J; Surveillance and Health Services Research, Intramural Research Department, American Cancer Society, Atlanta, GA, USA.
Ma J; Surveillance and Health Services Research, Intramural Research Department, American Cancer Society, Atlanta, GA, USA.
Jemal A; Surveillance and Health Services Research, Intramural Research Department, American Cancer Society, Atlanta, GA, USA.
Yabroff KR; Surveillance and Health Services Research, Intramural Research Department, American Cancer Society, Atlanta, GA, USA.; Pokaż więcej
Źródło :: Journal of the National Cancer Institute [J Natl Cancer Inst] 2021 Jan 19. Date of Electronic Publication: 2021 Jan 19.
Typ publikacji :: Journal Article
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 2 2.

Tytuł :: Optimizing Patient-Centered Psychosocial Care to Reduce Suicide Risk and Enhance Survivorship Outcomes Among Cancer Patients.
Autorzy :: Gage-Bouchard EA; Department of Cancer Prevention and Control, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
Pailler M; Department of Psychology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
Devine KA; Section of Pediatric Population Science, Outcomes, and Disparities Research, Division of Pediatric Hematology/Oncology, Rutgers Cancer Institute of New Jersey, The State University of New Jersey, Rutgers, NJ, USA.
Flores T; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.; Pokaż więcej
Źródło :: Journal of the National Cancer Institute [J Natl Cancer Inst] 2021 Jan 19. Date of Electronic Publication: 2021 Jan 19.
Typ publikacji :: Journal Article
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 3 3.

Tytuł :: Hypoxia-Guided Therapy for Human Papillomavirus-Associated Oropharynx Cancer.
Autorzy :: Burtness B; Department of Medicine, Yale School of Medicine, New Haven, CT, USA.; Yale Cancer Center, Yale School of Medicine, New Haven, CT, USA.
Contessa J; Yale Cancer Center, Yale School of Medicine, New Haven, CT, USA.; Department of Therapeutic Radiology, Yale School of Medicine, New Haven, CT, USA.; Pokaż więcej
Źródło :: Journal of the National Cancer Institute [J Natl Cancer Inst] 2021 Jan 12. Date of Electronic Publication: 2021 Jan 12.
Typ publikacji :: Journal Article
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 4 4.

Tytuł :: Precision Radiotherapy: Reduction in Radiation for Oropharyngeal Cancer in the 30 ROC Trial.
Autorzy :: Riaz N; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Immunogenomics and Precision Oncology Platform, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Sherman E; Department of Medical Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Pei X; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Schöder H; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Grkovski M; Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Paudyal R; Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Katabi N; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Selenica P; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Yamaguchi TN; UCLA, Department of Human Genetics, Los Angeles, CA, USA.; Informatics and Biocomputing Program, Ontario Institute for Cancer Research, Toronto, ON, USA.; Jonsson Comprehensive Cancer Centre, University of California, Los Angeles, CA, USA.
Ma D; Department of Radiation Oncology, Mayo Clinic, Rochester, MN, USA.
Lee SK; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Shah R; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Kumar R; Institute for Cancer Genetics, Columbia University, New York, NY, USA.
Kuo F; Immunogenomics and Precision Oncology Platform, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Ratnakumar A; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Aleynick N; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Brown D; Institute for Cancer Genetics, Columbia University, New York, NY, USA.
Zhang Z; Departmant of Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Hatzoglou V; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Liu LY; UCLA, Department of Human Genetics, Los Angeles, CA, USA.; Informatics and Biocomputing Program, Ontario Institute for Cancer Research, Toronto, ON, USA.; Jonsson Comprehensive Cancer Centre, University of California, Los Angeles, CA, USA.; Department of Medical Biophysics, University of Toronto, Toronto, ON, USA.; Vector Institute for Artificial Intelligence, Toronto, ON, USA.
Salcedo A; Informatics and Biocomputing Program, Ontario Institute for Cancer Research, Toronto, ON, USA.; Department of Medical Biophysics, University of Toronto, Toronto, ON, USA.
Tsai CJ; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
McBride S; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Morris LGT; Immunogenomics and Precision Oncology Platform, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Boyle J; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Singh B; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Higginson DS; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Damerla RR; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Paula ADC; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Price K; Divison of Medical Oncology, Mayo Clinic, Rochester, MN, USA.
Moore EJ; Department of Otolaryngology, Mayo Clinic, Rochester, MN, USA.
Garcia JJ; Department of Pathology, Mayo Clinic, Rochester, MN, USA.
Foote R; Department of Radiation Oncology, Mayo Clinic, Rochester, MN, USA.
Ho A; Department of Medical Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Wong RJ; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Chan TA; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Immunogenomics and Precision Oncology Platform, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Powell SN; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Boutros PC; UCLA, Department of Human Genetics, Los Angeles, CA, USA.; Informatics and Biocomputing Program, Ontario Institute for Cancer Research, Toronto, ON, USA.; Jonsson Comprehensive Cancer Centre, University of California, Los Angeles, CA, USA.; Department of Medical Biophysics, University of Toronto, Toronto, ON, USA.; Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON, USA.; Department of Urology, University of California, Los Angeles, CA, USA.; Institute for Precision Health, University of California, Los Angeles, CA, USA.
Humm JL; Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Shukla-Dave A; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Pfister D; Department of Medical Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Reis-Filho JS; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Lee N; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Pokaż więcej
Źródło :: Journal of the National Cancer Institute [J Natl Cancer Inst] 2021 Jan 12. Date of Electronic Publication: 2021 Jan 12.
Typ publikacji :: Journal Article
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 5 5.

Tytuł :: Neoadjuvant Immunotherapy for High-Risk, Resectable Malignancies: Scientific Rationale and Clinical Challenges.
Autorzy :: Krishnamoorthy M; Department of Microbiology & Immunology, University of Western Ontario, London, ON, Canada.; Cancer Research Laboratory Program, Lawson Health Research Institute, London, ON, Canada.
Lenehan JG; Division of Medical Oncology, Department of Oncology, University of Western Ontario, London, ON, Canada.
Vareki SM; Cancer Research Laboratory Program, Lawson Health Research Institute, London, ON, Canada.; Department of Pathology and Laboratory Medicine, University of Western Ontario, London, ON, Canada.; Division of Experimental Oncology, Department of Oncology, University of Western Ontario, London, ON, Canada.; Pokaż więcej
Źródło :: Journal of the National Cancer Institute [J Natl Cancer Inst] 2021 Jan 11. Date of Electronic Publication: 2021 Jan 11.
Typ publikacji :: Journal Article
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 6 6.

Tytuł :: Neoadjuvant Immunotherapy: An Evolving Paradigm Shift?
Autorzy :: Bilusic M; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Gulley JL; Genitourinary Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.; Pokaż więcej
Źródło :: Journal of the National Cancer Institute [J Natl Cancer Inst] 2021 Jan 11. Date of Electronic Publication: 2021 Jan 11.
Typ publikacji :: Journal Article
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 7 7.

Tytuł :: Re: Clinical Characteristics and Outcomes of COVID-19-Infected Cancer Patients: A Systematic Review and Meta-Analysis.
Autorzy :: Cottu P; Department of Medical Oncology, Institut Curie, Paris, France.
Bozec L; Department of Medical Oncology, Institut Curie, Saint-Cloud, France.
Basse C; Department of Medical Oncology, Institut Curie, Paris, France.
Paoletti X; Université de Versailles St Quentin, France.; Biostatistics, INSERM U900, Institut Curie, Saint-Cloud, France.; Pokaż więcej
Źródło :: Journal of the National Cancer Institute [J Natl Cancer Inst] 2021 Jan 06. Date of Electronic Publication: 2021 Jan 06.
Typ publikacji :: Journal Article
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 8 8.

Tytuł :: Response to Cottu, Bozec, Basse, and Paoletti.
Autorzy :: Zhang H; Laura and Isaac Perlmutter Cancer Center, New York University Langone Medical Center, New York, NY, USA.
Han H; Laura and Isaac Perlmutter Cancer Center, New York University Langone Medical Center, New York, NY, USA.
He T; Department of Biostatistics, Mailman School of Public Health, Columbia University, New York, NY, USA.
Labbe KE; Laura and Isaac Perlmutter Cancer Center, New York University Langone Medical Center, New York, NY, USA.
Hernandez AV; Health Outcomes, Policy, and Evidence Synthesis (HOPES) Group, University of Connecticut School of Pharmacy, Storrs, CT, USA.; Vicerrectorado de Investigación, Universidad San Ignacio de Loyola (USIL), Lima, Peru.
Chen H; Departments of Thoracic Surgery and State Key Laboratory of Genetic Engineering, Fudan University Shanghai Cancer Center, Shanghai, China.
Velcheti V; Laura and Isaac Perlmutter Cancer Center, New York University Langone Medical Center, New York, NY, USA.
Stebbing J; Department of Surgery and Cancer, Imperial College London, London, W12 0NN, UK.
Wong KK; Laura and Isaac Perlmutter Cancer Center, New York University Langone Medical Center, New York, NY, USA.; Pokaż więcej
Źródło :: Journal of the National Cancer Institute [J Natl Cancer Inst] 2021 Jan 06. Date of Electronic Publication: 2021 Jan 06.
Typ publikacji :: Journal Article
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 9 9.

Tytuł :: Using Prediction-Models to Reduce Persistent Racial/Ethnic Disparities in Draft 2020 USPSTF Lung-Cancer Screening Guidelines.
Autorzy :: Landy R; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland, USA.
Young CD; Department of Microbiology, Biochemistry and Immunology, Morehouse School of Medicine, Atlanta, Georgia, USA.
Skarzynski M; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland, USA.
Cheung LC; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland, USA.
Berg CD; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland, USA.
Rivera MP; Division of Pulmonary and Critical Care Medicine, University of North Carolina at Chapel Hill, North Carolina, USA.
Robbins HA; International Agency for Research on Cancer, Lyon, France.
Chaturvedi AK; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland, USA.
Katki HA; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland, USA.; Pokaż więcej
Źródło :: Journal of the National Cancer Institute [J Natl Cancer Inst] 2021 Jan 05. Date of Electronic Publication: 2021 Jan 05.
Typ publikacji :: Journal Article
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 10 10.

Tytuł :: Reducing Disparities in Lung Cancer Screening: It's Not so Black and White.
Autorzy :: Fedewa S; Office of the Chief and Scientific Medical Officer, Cancer Society, Atlanta, GA.
Silvestri GA; Division of Pulmonary and Critical Care Medicine, Medical University of South Carolina, Charleston, SC.; Pokaż więcej
Źródło :: Journal of the National Cancer Institute [J Natl Cancer Inst] 2021 Jan 05. Date of Electronic Publication: 2021 Jan 05.
Typ publikacji :: Journal Article
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 11 11.

Tytuł :: Breast Tumor Microenvironment in Black Women: A Distinct Signature of CD8+ T Cell Exhaustion.
Autorzy :: Yao S; Department of Cancer Prevention and Control, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
Cheng TD; Department of Cancer Prevention and Control, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.; Department of Epidemiology, University of Florida, Gainesville, FL, USA.
Elkhanany A; Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
Yan L; Department of Biostatistics and Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
Omilian A; Department of Cancer Prevention and Control, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
Abrams SI; Department of Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
Evans S; Department of Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
Hong CC; Department of Cancer Prevention and Control, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
Qi Q; Department of Biostatistics and Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
Davis W; Department of Cancer Prevention and Control, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
Liu S; Department of Biostatistics and Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
Bandera EV; Cancer Prevention and Control Program, Rutgers Cancer Institute of New Jersey, The State University of New Jersey, New Brunswick, NJ, USA.
Odunsi K; Department of Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
Takabe K; Breast Surgery, Department of Surgical Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
Khoury T; Department of Pathology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
Ambrosone CB; Department of Cancer Prevention and Control, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.; Pokaż więcej
Źródło :: Journal of the National Cancer Institute [J Natl Cancer Inst] 2021 Jan 05. Date of Electronic Publication: 2021 Jan 05.
Typ publikacji :: Journal Article
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 12 12.

Tytuł :: Predicting the Pathologic Complete Response After Neoadjuvant Pembrolizumab in Muscle-Invasive Bladder Cancer.
Autorzy :: Bandini M; San Raffaele Hospital and Scientific Institute, Milan, Italy.
Ross JS; Foundation Medicine, Cambridge, MA, USA.; Upstate Medical University, Syracuse, NY, USA.
Raggi D; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Gallina A; San Raffaele Hospital and Scientific Institute, Milan, Italy.
Colecchia M; Upstate Medical University, Syracuse, NY, USA.
Lucianò R; San Raffaele Hospital and Scientific Institute, Milan, Italy.
Giannatempo P; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Farè E; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Pederzoli F; San Raffaele Hospital and Scientific Institute, Milan, Italy.
Bianchi M; San Raffaele Hospital and Scientific Institute, Milan, Italy.
Colombo R; San Raffaele Hospital and Scientific Institute, Milan, Italy.
Gandaglia G; San Raffaele Hospital and Scientific Institute, Milan, Italy.
Fossati N; San Raffaele Hospital and Scientific Institute, Milan, Italy.
Marandino L; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Capitanio U; San Raffaele Hospital and Scientific Institute, Milan, Italy.
Deho' F; San Raffaele Hospital and Scientific Institute, Milan, Italy.
Ali SM; Foundation Medicine, Cambridge, MA, USA.
Madison R; Foundation Medicine, Cambridge, MA, USA.
Chung JH; Foundation Medicine, Cambridge, MA, USA.
Salonia A; San Raffaele Hospital and Scientific Institute, Milan, Italy.; Vita-Salute San Raffaele University, Milan, Italy.
Briganti A; San Raffaele Hospital and Scientific Institute, Milan, Italy.; Vita-Salute San Raffaele University, Milan, Italy.
Montorsi F; San Raffaele Hospital and Scientific Institute, Milan, Italy.; Vita-Salute San Raffaele University, Milan, Italy.
Necchi A; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Pokaż więcej
Źródło :: Journal of the National Cancer Institute [J Natl Cancer Inst] 2021 Jan 04; Vol. 113 (1), pp. 48-53.
Typ publikacji :: Journal Article
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 13 13.

Tytuł :: Computational Modeling of Neuropsychological Test Performance to Disentangle Impaired Cognitive Processes in Cancer Patients.
Autorzy :: Agelink van Rentergem JA; Department of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Psychology, University of Amsterdam, Amsterdam, The Netherlands.
Vermeulen IE; Department of Communication Science, VU University Amsterdam, Amsterdam, The Netherlands.
Lee Meeuw Kjoe PR; Department of Psychology, University of Amsterdam, Amsterdam, The Netherlands.
Schagen SB; Department of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Psychology, University of Amsterdam, Amsterdam, The Netherlands.; Pokaż więcej
Źródło :: Journal of the National Cancer Institute [J Natl Cancer Inst] 2021 Jan 04; Vol. 113 (1), pp. 99-102.
Typ publikacji :: Journal Article
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 14 14.

Tytuł :: Prostate Cancer Incidence 5 Years After US Preventive Services Task Force Recommendations Against Screening.
Autorzy :: Jemal A; Surveillance and Health Services Research, American Cancer Society, Atlanta, GA, USA.
Culp MB; Surveillance and Health Services Research, American Cancer Society, Atlanta, GA, USA.
Ma J; Surveillance and Health Services Research, American Cancer Society, Atlanta, GA, USA.
Islami F; Surveillance and Health Services Research, American Cancer Society, Atlanta, GA, USA.
Fedewa SA; Surveillance and Health Services Research, American Cancer Society, Atlanta, GA, USA.; Pokaż więcej
Źródło :: Journal of the National Cancer Institute [J Natl Cancer Inst] 2021 Jan 04; Vol. 113 (1), pp. 64-71.
Typ publikacji :: Journal Article
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 15 15.

Tytuł :: Accuracy and Efficiency of Deep-Learning-Based Automation of Dual Stain Cytology in Cervical Cancer Screening.
Autorzy :: Wentzensen N; Affiliations of authors: Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
Lahrmann B; Steinbeis Transfer Center for Medical Systems Biology, Heidelberg, Germany.
Clarke MA; Affiliations of authors: Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
Kinney W; Global Coalition Against Cervical Cancer, Arlington, VA, USA.
Tokugawa D; Kaiser Permanente TPMG Regional Laboratory, Berkeley, CA, USA.
Poitras N; Kaiser Permanente TPMG Regional Laboratory, Berkeley, CA, USA.
Locke A; Kaiser Permanente TPMG Regional Laboratory, Berkeley, CA, USA.
Bartels L; Hamamatsu Tissue Imaging and Analysis Center (TIGA), BIOQUANT, University Heidelberg, Heidelberg, Germany.; National Center of Tumor Diseases, Medical Oncology, University Hospital Heidelberg, Heidelberg, Germany.
Krauthoff A; Hamamatsu Tissue Imaging and Analysis Center (TIGA), BIOQUANT, University Heidelberg, Heidelberg, Germany.; National Center of Tumor Diseases, Medical Oncology, University Hospital Heidelberg, Heidelberg, Germany.
Walker J; University of Oklahoma, Oklahoma City, OK, USA.
Zuna R; University of Oklahoma, Oklahoma City, OK, USA.
Grewal KK; Kaiser Permanente TPMG Regional Laboratory, Berkeley, CA, USA.
Goldhoff PE; Kaiser Permanente TPMG Regional Laboratory, Berkeley, CA, USA.
Kingery JD; Kaiser Permanente TPMG Regional Laboratory, Berkeley, CA, USA.
Castle PE; Albert Einstein College of Medicine, Bronx, NY, USA.
Schiffman M; Affiliations of authors: Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
Lorey TS; Kaiser Permanente TPMG Regional Laboratory, Berkeley, CA, USA.
Grabe N; Steinbeis Transfer Center for Medical Systems Biology, Heidelberg, Germany.; Hamamatsu Tissue Imaging and Analysis Center (TIGA), BIOQUANT, University Heidelberg, Heidelberg, Germany.; National Center of Tumor Diseases, Medical Oncology, University Hospital Heidelberg, Heidelberg, Germany.; Pokaż więcej
Źródło :: Journal of the National Cancer Institute [J Natl Cancer Inst] 2021 Jan 04; Vol. 113 (1), pp. 72-79.
Typ publikacji :: Journal Article
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 16 16.

Tytuł :: One Step Further Toward Defining the Exceptional Cancer Responder.
Autorzy :: Ford JM; Medicine (Oncology) and Genetics, Stanford University School of Medicine, Stanford, CA, USA.
Mitchell BS; Medicine (Oncology, Hematology), Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.; Pokaż więcej
Źródło :: Journal of the National Cancer Institute [J Natl Cancer Inst] 2021 Jan 04; Vol. 113 (1), pp. 3-4.
Typ publikacji :: Journal Article
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 17 17.

Tytuł :: Multifactorial, Biomarker-Based Predictive Models for Immunotherapy Response Enter the Arena.
Autorzy :: Appleman LJ; Division of Hematology/Oncology, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.; Pokaż więcej
Źródło :: Journal of the National Cancer Institute [J Natl Cancer Inst] 2021 Jan 04; Vol. 113 (1), pp. 7-8.
Typ publikacji :: Journal Article
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 18 18.

Tytuł :: Overdiagnosis in the Age of Digital Cancer Screening.
Autorzy :: Brawley OW; Department of Oncology, Johns Hopkins School of Medicine, Baltimore, MD, USA.; Department of Epidemiology, Bloomberg School of Public Health, Baltimore, MD, USA.
Paller CJ; Department of Oncology, Johns Hopkins School of Medicine , Baltimore, MD, USA.; Department of Urology, Johns Hopkins School of Medicine, Baltimore, MD, USA.; Pokaż więcej
Źródło :: Journal of the National Cancer Institute [J Natl Cancer Inst] 2021 Jan 04; Vol. 113 (1), pp. 1-2.
Typ publikacji :: Journal Article
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 19 19.

Tytuł :: Scaling Up the Surveillance of Childhood Cancer: A Global Roadmap.
Autorzy :: Piñeros M; Section of Cancer Surveillance, International Agency for Research on Cancer, Lyon, France.
Mery L; Section of Cancer Surveillance, International Agency for Research on Cancer, Lyon, France.
Soerjomataram I; Section of Cancer Surveillance, International Agency for Research on Cancer, Lyon, France.
Bray F; Section of Cancer Surveillance, International Agency for Research on Cancer, Lyon, France.
Steliarova-Foucher E; Section of Cancer Surveillance, International Agency for Research on Cancer, Lyon, France.; Pokaż więcej
Źródło :: Journal of the National Cancer Institute [J Natl Cancer Inst] 2021 Jan 04; Vol. 113 (1), pp. 9-15.
Typ publikacji :: Journal Article
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 20 20.

Tytuł :: The Exceptional Responders Initiative: Feasibility of a National Cancer Institute Pilot Study.
Autorzy :: Conley BA; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA.
Staudt L; Center for Cancer Genomics, National Cancer Institute, Bethesda, MD, USA.
Takebe N; Developmental Therapeutics Clinic, National Cancer Institute, Bethesda, MD, USA.
Wheeler DA; Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX, USA.
Wang L; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Cardenas MF; Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX, USA.
Korchina V; Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX, USA.
Zenklusen JC; Center for Cancer Genomics, National Cancer Institute, Bethesda, MD, USA.
McShane LM; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA.
Tricoli JV; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA.
Williams PM; Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
Lubensky I; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA.
O'Sullivan-Coyne G; Developmental Therapeutics Clinic, National Cancer Institute, Bethesda, MD, USA.
Kohn E; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA.
Little RF; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA.
White J; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA.
Malik S; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA.
Harris LN; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA.
Mann B; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA.
Weil C; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA.
Tarnuzzer R; Center for Cancer Genomics, National Cancer Institute, Bethesda, MD, USA.
Karlovich C; Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
Rodgers B; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA.
Shankar L; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA.
Jacobs PM; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA.
Nolan T; Department of Biomedical Informatics, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Berryman SM; Department of Biomedical Informatics, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Gastier-Foster J; Nationwide Children's Hospital, Columbus, OH, USA; Van Andel Research Institute, Grand Rapids, MI, USA.
Bowen J; Nationwide Children's Hospital, Columbus, OH, USA; Van Andel Research Institute, Grand Rapids, MI, USA.
Leraas K; Nationwide Children's Hospital, Columbus, OH, USA; Van Andel Research Institute, Grand Rapids, MI, USA.
Shen H; Van Andel Research Institute, Grand Rapids, MI, USA.
Laird PW; Van Andel Research Institute, Grand Rapids, MI, USA.
Esteller M; Josep Carreras Leukaemia Research Institute, Badalona, Barcelona, Catalonia, Spain.
Miller V; Foundation Medicine Inc, Cambridge, MA, USA.
Johnson A; Foundation Medicine Inc, Cambridge, MA, USA.
Edmondson EF; Pathology and Histology Laboratory, Leidos Biomedical Research, Inc, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
Giordano TJ; Department of Pathology, University of Michigan, Ann Arbor, MI, USA.
Kim B; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA.
Ivy SP; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD, USA.; Pokaż więcej
Źródło :: Journal of the National Cancer Institute [J Natl Cancer Inst] 2021 Jan 04; Vol. 113 (1), pp. 27-37.
Typ publikacji :: Journal Article
: Czasopismo naukowe

Szczegóły

Informacja

Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Journal of the National Cancer Institute [J Natl Cancer Inst] NLMUID: 7503089"" wg kryterium: JN

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Język